MRI-RP-2021: Post Radiotherapy MRI Based AI System to Predict Radiation Proctitis for Pelvic Cancers

Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04918992
Collaborator
(none)
400
4
37.3
100
2.7

Study Details

Study Description

Brief Summary

In this study, investigators utilize a Artificial Intelligence (AI) supportive system to predict radiation proctitis for patients with pelvic cancers underwent radiotherapy. By the system, whether the participants achieve the radiation proctitis will be identified based on the radiomics features extracted from the post radiotherapy Magnetic Resonance Imaging (MRI) . The predictive power to discriminate the radiation proctitis individuals from non-radiation proctitis patients, will be validated in this multicenter, prospective clinical study.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Artificial Intelligence

Detailed Description

This is a multicenter, prospective, observational clinical study for seeking out a better way to predict the radiation proctitis in patients with pelvic cancers based on the post-radiotherapy Magnetic Resonance Imaging (MRI) data. Patients who have been pathologically diagnosed as pelvic cancers will be enrolled from the Sixth Affiliated Hospital of Sun Yat-sen University, Sir Run Run Shaw Hospital and the Third Affiliated Hospital of Kunming Medical College. Patients with pelvic cancers who received radiotherapy will be enrolled and their post-radiotherapy MRI images will be used to predict their radiation proctitis or not. The clinical symptoms, endoscopic findings, imaging and histopathology as a standard. The predictive efficacy will be tested in this multicenter, prospective clinical study.

Study Design

Study Type:
Observational
Anticipated Enrollment :
400 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Post-radiotherapy MRI Based AI System to Predict Radiation Proctitis for Pelvic Cancers
Anticipated Study Start Date :
Jun 22, 2021
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Outcome Measures

Primary Outcome Measures

  1. The area under curve (AUC) of Receiver Operating Characteristic (ROC) curves of AI prediction system in prediction radiation proctitis [baseline]

    The area under curve (AUC) of Receiver Operating Characteristic (ROC) curves of AI prediction system in identifying the radiation proctitis candidates from non-radiation proctitis individuals among pelvic cancers underwent radiotherapy

Secondary Outcome Measures

  1. The specificity of AI prediction system in prediction radiation proctitis [baseline]

    The specificity of AI prediction system in identifying the radiation proctitis candidates from non-radiation proctitis individuals among pelvic cancers underwent radiotherapy

Other Outcome Measures

  1. The sensitivity of AI prediction system in prediction the radiation proctitis candidates [baseline]

    The sensitivity of AI prediction system in identifying the radiation proctitis candidates from non-radiation proctitis individuals among pelvic cancers underwent radiotherapy

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • pathologically diagnosed as pelvic tumours

  • intending to receive or undergoing radiotherapy

  • MRI (high-solution T2-weighted imaging, contrast-enhanced T1-weighted imaging, and diffusion-weighted imaging are required) examination is completed after radiotherapy

Exclusion Criteria:
  • insufficient imaging quality of MRI (e.g., lack of sequence, motion artifacts)

  • incomplete radiotherapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 the Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou Guangdong China 510000
2 the Sixth Affiliated Hospital of Sun Yat-sen University GuangZhou Guangdong China 510655
3 The Third Affiliated Hospital of Kunming Medical College Kunming Yunnan China 650000
4 Sir Run Run Shaw Hospital HangZhou Zhejiang China 310000

Sponsors and Collaborators

  • Sixth Affiliated Hospital, Sun Yat-sen University

Investigators

  • Study Chair: Xinjuan Fan, MD, Sixth Affiliated Hospital, Sun Yat-sen University
  • Principal Investigator: Weidong Han, MD, Sir Run Run Shaw Hospital
  • Principal Investigator: Zhenhui Li, MD, The Third Affiliated Hospital of Kunming Medical College.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sixth Affiliated Hospital, Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT04918992
Other Study ID Numbers:
  • MRI-RP
First Posted:
Jun 9, 2021
Last Update Posted:
Jun 9, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sixth Affiliated Hospital, Sun Yat-sen University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 9, 2021